$1,000 invested Gilead Sciences Inc. (2021)
NASDAQ · GILD · reinvest dividends · adjusted close
●Result2021-01-04 — 2026-08-28
Today you would have
$2,953
+$1,953 (+195.32%)
GILDSPY (benchmark)
- Entry price
- $49.33
- Current price
- $145.68
- Shares
- 20.2715
- CAGR
- +21.14%
- Max Drawdown
- -26.59%
- vs SPY
- +71.22 pp
✦The story
Investing $1,000 in Gilead Sciences at the start of 2021 would have grown to $2,953 by mid-2026, a total return of +195.3%. The company entered the period known for its antiviral drugs, including treatments used during the COVID-19 pandemic, and later saw its shares re-rate higher. That beat the S&P 500's +124.1% over the same years.
#Related scenariosfor comparison
Other years for GILD